Page 23 - Prussian Blue News Today : Breaking News, Live Updates & Top Stories | Vimarsana

30 miles away at kaiser hospital, doctor lapointe was waiting as well. three days had passed since she sent out brigida samples. brigida, in pain the whole time. finally, the lab results came back. just as he suspected, it was thallium. a lot of it. brigida husband and young son seemed to be clear of the toxic metal, but she was in serious danger. >> her levels were off of the charts? >> they really were. >> more than 1000 times the acceptable level. >> wow, that is unbelievable. >> a hospital staffer had driven through the night to get hold of prussian blue pills. doctor lapointe started brig...

And we finally find storage. they're all confidential stored sites, but we found one. >> prussian blue it's so hard to find, because it's also an antidote for radiation poisoning. the u.s. government keeps it under close guard, stockpiled in case of a nuclear attack. >> so, no one wants to give me an antidote before proven him. because, we don't just throw around prussian blue. we >> have several tripwire set up, in this case the prussian blue patient was in san diego, and we were notified immediately that a production order. >> john cale is a special agent with the fbi, and san diego. his foc...

I'm trying to advocate all these different people, lots of hours on the phone. trying to get somebody on the phone saying, this was going to die. as soon as we sent the test, we said, how do we get the antidote? >> he wanted to get ready as soon as results came in. what is the antidote? >> so, the antidote is called oppression blue. >> you've probably seen impression blue in paint. yes, paint. it's been used as a pigment, since the 1700s. you can see it here, in vincent van gogh's starry night. it wasn't until 1965 that scientists discovered prussian blue could be uses antidote. it works by sp...

Medesis Pharma wishes to accelerate the development of its antinuclear products and provides an update on its strategy Montpellier (France), April, 5,...

Montpellier (France), April, 5, 2022 - 8:45am – Medesis Pharma (ISIN: FR0010844464, Ticker: ALMDP), a pharmaceutical biotechnology company developing drug candidates with its proprietary buccal active ingredient delivery technology, Aonys®, publishes an information note on the three future drugs in develop...